Gainers
- TC BioPharm (Holdings) TCBP shares rose 16.5% to $0.74 during Wednesday's after-market session. Trading volume for this security closed at 344.0K, accounting for 28.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.7 million.
- Solid Biosciences SLDB shares rose 15.87% to $0.59. The market value of their outstanding shares is at $66.4 million.
- Minerva Neurosciences NERV shares rose 9.92% to $0.4. The market value of their outstanding shares is at $17.1 million.
- Biotricity BTCY stock moved upwards by 9.09% to $1.2. The company's market cap stands at $61.6 million.
- Trevena TRVN shares rose 8.74% to $0.24. The market value of their outstanding shares is at $39.7 million.
- AcelRx Pharmaceuticals ACRX stock increased by 8.64% to $0.25. The company's market cap stands at $36.7 million.
Losers
- Genocea Biosciences GNCA shares declined by 13.1% to $0.08 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 39.3 million shares, which is 1133.4 percent of its average volume over the last 100 days. The company's market cap stands at $4.7 million.
- SpringWorks Therapeutics SWTX shares fell 5.06% to $31.02. The company's market cap stands at $1.5 billion.
- Motus GI Hldgs MOTS stock decreased by 5.01% to $0.28. This security traded at a volume of 4.7 million shares come close, making up 821.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $15.6 million.
- icad ICAD stock decreased by 4.88% to $3.32. The market value of their outstanding shares is at $83.6 million.
- BioXcel Therapeutics BTAI stock declined by 4.72% to $10.91. The company's market cap stands at $305.3 million.
- Mirum Pharmaceuticals MIRM shares declined by 4.71% to $24.49. The company's market cap stands at $779.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in